Delivery Order SPE2DB20D7061-SPE2DB24FSPA0

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The $4,988.83 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense (DoD). Amerisourcebergen holds a larger single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $6,102.20 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Telmisartan-HCTZ 80-25 mg tablets. The $5,229.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance period through May 16, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite...
This is a federal contract award valued at $4,481.65 to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm fixed-price delivery order contract with a completion date of July 1, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.53 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $11,391.18 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit doses of 30s. This is an unset-aside firm fixed-price contract with an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office Division, is a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,644.21 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of February 6, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,468.85 Firm Fixed Price Delivery Order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. This award is not associated with a set-aside program. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, and the Department of Justice Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,644.66 firm fixed price delivery order is for the supply of 4,568,142,116 units of telmisartan-HCTZ 40-12.5 mg tablets. The contract has a completion date of May 6, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,390.59, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSPA0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The award, valued at $3,897.48, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business type.

Generated 10/8/24, 9:19 AM